Graph Therapeutics vs Kamada Pharmaceuticals
Graph Therapeutics vs Kamada Pharmaceuticals, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Graph Therapeutics is on 44/100 and Kamada Pharmaceuticals on 50/100.
Where each one leads
Graph Therapeutics
Leads on none of the measures we hold for both companies.
Kamada Pharmaceuticals
- our overall score: 50/100 against 44/100
- domain rating: 49/100 against 27/100
- funding raised: $150M against $5.0M
At a glance
| Measure | Graph Therapeutics | Kamada Pharmaceuticals |
|---|---|---|
| What it is | Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis. | Global biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions. |
| Category | Biotechnology, Artificial Intelligence, Healthcare, Drug Discovery | Biopharma, Plasma-derived therapeutics, Orphan diseases, Immunology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Pharmaceuticals |
| Founded | 2021 | 1990 |
| Headquarters | Boston, Austria | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Graph Therapeutics | Kamada Pharmaceuticals |
|---|---|---|
| Total funding | $5.0M | $150M |
| Latest round | Funding Round | Not published |
| LinkedIn followers | 2,302 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Graph Therapeutics | Kamada Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 50/100 |
| Traction | 33/100 | 40/100 |
| Team | Not published | 70/100 |
| Search visibility | 42/100 | 14/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 27/100 | 49/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Graph Therapeutics | Kamada Pharmaceuticals |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Framer | WordPress |
| Frameworks | Not detected | Jquery |
Graph Therapeutics vs Kamada Pharmaceuticals: common questions
Which is better, Graph Therapeutics or Kamada Pharmaceuticals?
On our 0-100 score Kamada Pharmaceuticals rates higher (50/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Graph Therapeutics and Kamada Pharmaceuticals compare on the numbers?
Kamada Pharmaceuticals leads on our overall score (50/100 against 44/100), domain rating (49/100 against 27/100), funding raised ($150M against $5.0M).
Read the full Graph Therapeutics review and pricing or the Kamada Pharmaceuticals review and pricing. You can also browse other Graph Therapeutics alternatives we track.